BACKGROUND: Endovascular aortic aneurysm repair (EVAR) is often offered to patients with abdominal aortic aneurysms (AAAs) considered preoperatively to be unfit for open AAA repair (oAAA). This study describes the short- and long-term outcomes of patients undergoing EVAR with AAAs <6.5 cm who are considered unfit for oAAA. METHODS AND RESULTS: We analyzed elective EVARs for AAAs <6.5 cm diameter in the Vascular Study Group of New England (2003-2011). Patients were designated as fit or unfit for oAAA by the treating surgeon. End points included in-hospital major adverse events and long-term mortality. We identified patient characteristics associated with being unfit for open repair and predictors of survival using multivariable analyses. Of 1653 EVARs, 309 (18.7%) patients were deemed unfit for oAAA. These patients were more likely to have advanced age, cardiac disease, chronic obstructive pulmonary disease, and larger aneurysms at the time of repair (54 versus 56 mm, P=0.001). Patients unfit for oAAA had higher rates of cardiac (7.8% versus 3.1%, P<0.01) and pulmonary (3.6 versus 1.6, P<0.01) complications and worse survival rates at 5 years (61% versus 80%; log rank P<0.01) compared with those deemed fit for oAAA. Finally, patients designated as unfit for oAAA had worse survival, even adjusting for patient characteristics and aneurysm size (hazard ratio, 1.6; 95% confidence interval, 1.2-2.2; P<0.01). CONCLUSIONS: In patients with AAAs <6.5 cm, designation by the operating surgeon as unfit for oAAA provides insight into both short- and long-term efficacy of EVAR. Patients unable to tolerate oAAA may not benefit from EVAR unless their risk of AAA rupture is very high.
BACKGROUND:Endovascular aortic aneurysm repair (EVAR) is often offered to patients with abdominal aortic aneurysms (AAAs) considered preoperatively to be unfit for open AAA repair (oAAA). This study describes the short- and long-term outcomes of patients undergoing EVAR with AAAs <6.5 cm who are considered unfit for oAAA. METHODS AND RESULTS: We analyzed elective EVARs for AAAs <6.5 cm diameter in the Vascular Study Group of New England (2003-2011). Patients were designated as fit or unfit for oAAA by the treating surgeon. End points included in-hospital major adverse events and long-term mortality. We identified patient characteristics associated with being unfit for open repair and predictors of survival using multivariable analyses. Of 1653 EVARs, 309 (18.7%) patients were deemed unfit for oAAA. These patients were more likely to have advanced age, cardiac disease, chronic obstructive pulmonary disease, and larger aneurysms at the time of repair (54 versus 56 mm, P=0.001). Patients unfit for oAAA had higher rates of cardiac (7.8% versus 3.1%, P<0.01) and pulmonary (3.6 versus 1.6, P<0.01) complications and worse survival rates at 5 years (61% versus 80%; log rank P<0.01) compared with those deemed fit for oAAA. Finally, patients designated as unfit for oAAA had worse survival, even adjusting for patient characteristics and aneurysm size (hazard ratio, 1.6; 95% confidence interval, 1.2-2.2; P<0.01). CONCLUSIONS: In patients with AAAs <6.5 cm, designation by the operating surgeon as unfit for oAAA provides insight into both short- and long-term efficacy of EVAR. Patients unable to tolerate oAAA may not benefit from EVAR unless their risk of AAA rupture is very high.
Authors: Christopher N Compton; Ellen D Dillavou; Maureen K Sheehan; Robert Y Rhee; Michel S Makaroun Journal: J Vasc Surg Date: 2005-10 Impact factor: 4.268
Authors: Monique Prinssen; Eric L G Verhoeven; Jaap Buth; Philippe W M Cuypers; Marc R H M van Sambeek; Ron Balm; Erik Buskens; Diederick E Grobbee; Jan D Blankensteijn Journal: N Engl J Med Date: 2004-10-14 Impact factor: 91.245
Authors: Jack L Cronenwett; Donald S Likosky; Margaret T Russell; Jens Eldrup-Jorgensen; Andrew C Stanley; Brian W Nolan Journal: J Vasc Surg Date: 2007-10-24 Impact factor: 4.268
Authors: Frank A Lederle; Julie A Freischlag; Tassos C Kyriakides; Frank T Padberg; Jon S Matsumura; Ted R Kohler; Peter H Lin; Jessie M Jean-Claude; Dolores F Cikrit; Kathleen M Swanson; Peter N Peduzzi Journal: JAMA Date: 2009-10-14 Impact factor: 56.272
Authors: Shaunak S Adkar; Megan C Turner; Harold J Leraas; Brian F Gilmore; Uttara Nag; Ryan S Turley; Cynthia K Shortell; Leila Mureebe Journal: J Vasc Surg Date: 2017-09-23 Impact factor: 4.268
Authors: Foeke Nauta; Hector de Beaufort; Firas F Mussa; Carlo De Vincentiis; Atsushi Omura; Hitoshi Matsuda; Santi Trimarchi Journal: Ann Cardiothorac Surg Date: 2019-09
Authors: Jesse A Columbo; Pablo Martinez-Camblor; Todd A MacKenzie; Ravinder Kang; Spencer W Trooboff; Philip P Goodney; A James O'Malley Journal: J Vasc Surg Date: 2018-06-15 Impact factor: 4.268
Authors: Andrew W Hoel; Adrienne E Faerber; Kayla O Moore; Niveditta Ramkumar; Benjamin S Brooke; Salvatore T Scali; Art Sedrakyan; Philip P Goodney Journal: J Vasc Surg Date: 2017-02-17 Impact factor: 4.268
Authors: Juliet Blakeslee-Carter; Zdenek Novak; John Axley; William F Gaillard; Graeme E McFarland; Benjamin J Pearce; Emily L Spangler; Marc A Passman; Adam W Beck Journal: Ann Vasc Surg Date: 2022-04-13 Impact factor: 1.607
Authors: Jesse A Columbo; Pablo Martinez-Camblor; Todd A MacKenzie; Douglas O Staiger; Ravinder Kang; Philip P Goodney; A James O'Malley Journal: JAMA Netw Open Date: 2018-09-07